BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
Fuji
Moodys
Accenture
Medtronic
Chinese Patent Office
Covington
QuintilesIMS
Healthtrust

Generated: January 17, 2018

DrugPatentWatch Database Preview

PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

When do Propranolol Hydrochloride And Hydrochlorothiazide patents expire, and when can generic versions of Propranolol Hydrochloride And Hydrochlorothiazide launch?

Propranolol Hydrochloride And Hydrochlorothiazide is a drug marketed by Actavis Elizabeth, Ani Pharms Inc, Ivax Sub Teva Pharms, Mylan, Sandoz, Warner Chilcott, and Watson Labs. and is included in seventeen NDAs.

The generic ingredient in PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
Summary for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Pharmacology for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070851-001 May 15, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071501-001 Dec 18, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071552-001 Dec 1, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 072042-001 Mar 14, 1988 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071061-001 Aug 26, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071553-001 Dec 1, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071498-001 Dec 18, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071772-001 Jan 26, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070852-001 May 15, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070704-001 Oct 1, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
McKesson
QuintilesIMS
Covington
Colorcon
Citi
Baxter
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot